Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein

被引:61
作者
Price, JD
Schaumburg, J
Sandin, C
Atkinson, JP
Lindahl, G
Kemper, C
机构
[1] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Grad Program Immunol, St Louis, MO 63110 USA
[3] Lund Univ, Dept Lab Med, Lund, Sweden
关键词
D O I
10.4049/jimmunol.175.2.677
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) participate in the control of the immune response. In the human system, an IL-10-secreting, T regulatory type 1 cell (Tr1)-like subset of Tregs can be induced by concurrent cross-linking of the TCR and CD46 on naive CD4(+) T cells. Because many viral and bacterial pathogens, including the major human pathogen Streptococcus pyogenes, bind to CD46, we asked whether this bacterium can directly induce Tr1-like cells through the streptococcal ligand for CD46, the M protein. The M5 and M22 proteins were found to induce T cells to develop into the IL-10-producing Tr1-like phenotype. Moreover, whole M5-expressing bacteria, but not isogenic M-negative bacteria, led to proliferation and IL-10 secretion by T cells. The interaction between the M5 protein and T cells was dependent on CD46 and the conserved C repeat region of M5. Supernatants derived from T cells stimulated with M proteins or M protein-expressing bacteria suppressed bystander T cell proliferation through IL-10 secretion. In addition, activation of CD46 through streptococcal M protein induced the expression of granzyme B, providing a second means for these cells to regulate an immune response. These findings suggest that binding to CD46 and exploiting its signaling pathway may represent a strategy employed by a number of important human pathogens to induce directly an immunosuppressive/regulatory phenotype in T cells.
引用
收藏
页码:677 / 684
页数:8
相关论文
共 54 条
[11]   High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements [J].
Dombek, PE ;
Cue, D ;
Sedgewick, J ;
Lam, H ;
Ruschkowski, S ;
Finlay, BB ;
Cleary, PP .
MOLECULAR MICROBIOLOGY, 1999, 31 (03) :859-870
[12]   Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates:: emm103 to emm124 [J].
Facklam, RF ;
Martin, DR ;
Lovgren, M ;
Johnson, DR ;
Efstratiou, A ;
Thompson, TA ;
Gowan, S ;
Kriz, P ;
Tyrrell, GJ ;
Kaplan, E ;
Beall, B .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :28-38
[13]   Development and function of CD25+CD4+ regulatory T cells [J].
Fehérvari, Z ;
Sakaguchi, S .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (02) :203-208
[14]   STREPTOCOCCAL M-PROTEIN - MOLECULAR DESIGN AND BIOLOGICAL BEHAVIOR [J].
FISCHETTI, VA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (03) :285-314
[15]   Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46) [J].
Giannakis, E ;
Jokiranta, TS ;
Ormsby, RJ ;
Duthy, TG ;
Male, DA ;
Christiansen, D ;
Fischetti, VA ;
Bagley, C ;
Loveland, BE ;
Gordon, DL .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4585-4592
[16]   Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells [J].
Grossman, WJ ;
Verbsky, JW ;
Tollefsen, BL ;
Kemper, C ;
Atkinson, JP ;
Ley, TJ .
BLOOD, 2004, 104 (09) :2840-2848
[17]   Human T regulatory cells can use the perforin pathway to cause autologous target cell death [J].
Grossman, WJ ;
Verbsky, JW ;
Barchet, W ;
Colonna, M ;
Atkinson, JP ;
Ley, TJ .
IMMUNITY, 2004, 21 (04) :589-601
[18]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[19]   EPIDEMIOLOGIC ANALYSIS OF GROUP-A STREPTOCOCCAL SEROTYPES ASSOCIATED WITH SEVERE SYSTEMIC INFECTIONS, RHEUMATIC-FEVER, OR UNCOMPLICATED PHARYNGITIS [J].
JOHNSON, DR ;
STEVENS, DL ;
KAPLAN, EL .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :374-382
[20]  
Johnsson E, 1998, J IMMUNOL, V161, P4894